ACME Research Solutions Expands In Vitro Research Services to Singapore
Date
9/20/2024 2:35:47 AM
(MENAFNEditorial) ACME Research Solutions, a leading provider of Pharmaceutical research and development services, is proud to announce the expansion of its in vitro research services to Singapore. This move is aimed at providing high-quality in vitro cytotoxicity assays, a key technique used in evaluating the potential toxicity of compounds on cultured cell lines, to researchers and pharmaceutical companies in the region.
In vitro cytotoxicity assays are essential in the early stages of drug discovery and development, as they help predict the safety of compounds before further testing. ACME Research Solutions, with its state-of-the-art equipment and expertise, aims to support both academic institutions and industrial partners in Singapore by offering reliable and reproducible results for their research.
Director’s Statement
Akhilesh Vats, Director of ACME Research Solutions, expressed his enthusiasm for the company’s latest expansion:
"We are excited to bring our advanced in vitro research services to Singapore, a hub for scientific and pharmaceutical innovation. Our goal is to provide researchers in Singapore with the tools and support they need to accelerate their discoveries while maintaining the highest standards of scientific rigor. We believe that our cytotoxicity assays will play a crucial role in the region’s research landscape, especially in drug discovery and biomedical research."
ACME Research Solutions is known for its commitment to quality and precision, providing services that meet international standards. The company has a strong reputation for supporting researchers through every stage of the scientific process, from assay design to data interpretation. By extending its services to Singapore, ACME Research Solutions aims to contribute to the growing demand for advanced in vitro research in the region.
Researchers, universities, and biotech companies interested in learning more about ACME Research Solutions' in vitro cytotoxicity assay services are encouraged to contact the company directly for further details.
MENAFN20092024000070016748ID1108695390
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.